Data spanning the past 90 days through February 19, 2026 reveals that Larimar Therapeutics's three principal insider shareholders consist of Director James E Flynn (7.32Mn shares), Director Thomas Edward Hamilton (507.59K shares), President And Ceo Carole Ben-Maimon (368.28K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| James E Flynn | 7,321,129 | 04 Aug, 2025 | |
| Thomas Edward Hamilton | 507,590 | 20 Sep, 2022 | |
| Carole Ben-Maimon | President And Ceo | 368,276 | 27 Jan, 2026 |
| Michael Celano | Chief Financial Officer | 215,785 | 27 Jan, 2026 |
| Gopi Shankar | Chief Development Officer | 76,443 | 27 Jan, 2026 |
| Russell Clayton | Chief Medical Officer | 71,443 | 27 Jan, 2026 |
| Joseph Truitt | 2,750 | 18 May, 2023 | |
| Frank E Thomas | 2,000 | 15 Feb, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Jan, 2026 | Michael Celano | Common Stock | A | 37,604 | $0.00 | 215,785 | D | A |
| 26 Jan, 2026 | Carole Ben-Maimon | Common Stock | A | 100,100 | $0.00 | 368,276 | D | A |
| 26 Jan, 2026 | Russell Clayton | Common Stock | A | 25,637 | $0.00 | 71,443 | D | A |
| 26 Jan, 2026 | Gopi Shankar | Common Stock | A | 25,637 | $0.00 | 76,443 | D | A |
| 31 Jul, 2025 | James E Flynn | - | - | 9,538,918 | I | |||
| 31 Jul, 2025 | James E Flynn | - | - | 9,538,945 | I | |||
| 31 Jul, 2025 | James E Flynn | - | - | 7,321,129 | I | |||
| 31 Jul, 2025 | James E Flynn | Common Stock | A | 2,599,932 | $3.20 | 7,321,129 | I | P |
| 31 Jul, 2025 | James E Flynn | Common Stock | A | 3,387,529 | $3.20 | 9,538,918 | I | P |
| 31 Jul, 2025 | James E Flynn | Common Stock | A | 3,387,539 | $3.20 | 9,538,945 | I | P |
| 22 Jan, 2025 | Michael Celano | Common Stock | A | 34,185 | $0.00 | 178,181 | D | A |
| 22 Jan, 2025 | Carole Ben-Maimon | - | - | 387,208 | D | |||
| 22 Jan, 2025 | Carole Ben-Maimon | Common Stock | A | 91,000 | $0.00 | 387,208 | D | A |
| 22 Jan, 2025 | Russell Clayton | Common Stock | A | 23,306 | $0.00 | 45,806 | D | A |
| 22 Jan, 2025 | Gopi Shankar | Common Stock | A | 23,306 | $0.00 | 50,806 | D | A |
| 16 Feb, 2024 | James E Flynn | Common Stock | A | 1,430,205 | $8.74 | 4,207,982 | I | P |
| 16 Feb, 2024 | James E Flynn | - | - | 6,151,389 | I | |||
| 16 Feb, 2024 | James E Flynn | Common Stock | A | 1,430,206 | $8.74 | 6,151,389 | I | P |
| 16 Feb, 2024 | James E Flynn | - | - | 6,151,406 | I | |||
| 16 Feb, 2024 | James E Flynn | Common Stock | A | 1,430,206 | $8.74 | 6,151,406 | I | P |